Targeting organ‑specific gene “switches” can reverse key markers of liver aging in mice, suggesting aging might be slowed one organ at a time rather than bodywide.

Rising hospital costs translate to increasing premiums, as insurers pass on increased spending. Patients may be impacted by this as much, if not more, than drug costs.

Deepfake X-rays generated by ChatGPT deceived expert doctors raising questions about insurance claims, cybersecurity and legal cases.

A blood test clarifies which gene variants truly cause congenital heart defects, linking diagnosis to more precise heart‑signal–targeted treatments.

Ultra-processed foods may be contributing to behavioralproblems in young children, according to a new study.

Dual‑action antibody fragments that trigger and then block alphavirus entry protected against lethal equine encephalitis and neutralized many related viruses in animals.

Stem-cell–enhanced in‑utero surgery for spina bifida safely protects the fetal spinal cord and has so far prevented shunt placement.

A tumor “don’t‑eat‑me” shield also hides pro‑immune danger signals; new antibodies that unmask this hidden cue could make cancers more vulnerable to immune attack.

Self‑amplifying RNA boosts a heart‑healing peptide, reducing scarring and improving heart function after a heart attack in animals as a potential add‑on therapy.

A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.